NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Cardiac Dimensions

Cardiac Dimensions

Private
Kirkland, WashingtonHealthcare & Life Scienceshttps://cardiacdimensions.com/

Last Round

Series E

Mar 20, 2025

Total Funding Raised

$180M

Company Overview

Cardiac Dimensions is a medical device company that develops interventional tools for the treatment of heart failure and mitral valve regurgitation.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

mitral regurgitationmitral annuloplastystructural heartminimally invasive heart surgeryheart failure treatmentpercutaneous valve repaircatheter-based interventioninterventional cardiologymitral valve repairtranscatheter mitral valve repairTMVRmedical devicemedtechheart valve technology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cardiac Dimensions Comparables

Compare Cardiac Dimensions with similar companies based on industry and business-model similarity.

Cardiac Dimensions comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Polares Medical
87%
Valcare Medical
83%
4C Medical Technologies, Inc.
83%

Cardiac Dimensions Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series EMar 20, 2025
Series DJan 5, 2023
Series CSep 29, 2020
Series BApr 26, 2018
VC RoundMar 11, 2015
VC Round
Apr 16, 2014

Key People

Founding team and executive leadership

Rick Wypych

President And Chief Executive Officer

Executive Team

Cardiac Dimensions Investors

Notable investors and investment history

Cardiac Dimensions investors
InvestorRounds
MPM CapitalSeries D
Frazier Healthcare PartnersSeries D
EQT Life SciencesSeries D, Series C, VC Round
Claret Capital PartnersSeries E
Arboretum VenturesVC Round, Series D, Series B, Series C
InterWest PartnersSeries D
Hostplus Superannuation FundSeries D, Series B, Series C, Series E

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 3, 2025

    William T. Abraham, MD, appointed as new Chief Medical Officer.

  • Mar 20, 2025

    $53M round completed.

Cardiac Dimensions Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cardiac Dimensions Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cardiac Dimensions's valuation, stock price, and market status.

Firmographic Details

HeadquartersKirkland, Washington
Employee Range72
Year Founded2001
Last FundingMar 20, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.